These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8174265)

  • 1. Identification of UrinAid-adulterated urine specimens by fluorometric analysis.
    Wu A; Schmalz J; Bennett W
    Clin Chem; 1994 May; 40(5):845-6. PubMed ID: 8174265
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of glutaraldehyde (UrinAid) on detection of abused drugs in urine by immunoassay.
    Goldberger BA; Caplan YH
    Clin Chem; 1994 Aug; 40(8):1605-6. PubMed ID: 8045013
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of glutaraldehyde adulteration of urine specimens on syva EMIT II drugs-of-abuse assays.
    George S; Braithwaite RA
    J Anal Toxicol; 1996; 20(3):195-6. PubMed ID: 8735202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of AdultaCheck 4 test strips for the detection of adulteration at the point of collection of urine specimens used for drugs-of-abuse testing.
    King EJ
    J Anal Toxicol; 1999; 23(1):72. PubMed ID: 10022215
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of spot tests with AdultaCheck 6 and Intect 7 urine test strips for detecting the presence of adulterants in urine specimens.
    Dasgupta A; Chughtai O; Hannah C; Davis B; Wells A
    Clin Chim Acta; 2004 Oct; 348(1-2):19-25. PubMed ID: 15369731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel spot tests for detecting the presence of zinc sulfate in urine, a newly introduced urinary adulterant to invalidate drugs of abuse testing.
    Welsh KJ; Dierksen JE; Actor JK; Dasgupta A
    Am J Clin Pathol; 2013 Oct; 140(4):572-8. PubMed ID: 24045556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxicological screening for drugs of abuse in samples adulterated with household chemicals.
    Uebel RA; Wium CA
    S Afr Med J; 2002 Jul; 92(7):547-9. PubMed ID: 12197198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid spot tests for detecting the presence of adulterants in urine specimens submitted for drug testing.
    Dasgupta A; Wahed A; Wells A
    Am J Clin Pathol; 2002 Feb; 117(2):325-9. PubMed ID: 11863230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adulterants in Urine Drug Testing.
    Fu S
    Adv Clin Chem; 2016; 76():123-63. PubMed ID: 27645818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of intect test strips for detecting adulteration of urine specimens used for drugs-of-abuse testing.
    King EJ
    J Anal Toxicol; 2000 Sep; 24(6):456. PubMed ID: 10999355
    [No Abstract]   [Full Text] [Related]  

  • 11. Papain: a novel urine adulterant.
    Burrows DL; Nicolaides A; Rice PJ; Dufforc M; Johnson DA; Ferslew KE
    J Anal Toxicol; 2005; 29(5):275-95. PubMed ID: 16105251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine testing for cocaine abuse: metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results.
    Cone EJ; Sampson-Cone AH; Darwin WD; Huestis MA; Oyler JM
    J Anal Toxicol; 2003 Oct; 27(7):386-401. PubMed ID: 14606991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine Drug Screens: Common False Positives and Negatives.
    Daniel J
    S D Med; 2015 Jun; 68(6):262-3. PubMed ID: 26137727
    [No Abstract]   [Full Text] [Related]  

  • 14. Analysis of morphine and codeine in samples adulterated with Stealth.
    Cody JT; Valtier S; Kuhlman J
    J Anal Toxicol; 2001 Oct; 25(7):572-5. PubMed ID: 11599602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower Cutoffs for LC-MS/MS Urine Drug Testing Indicates Better Patient Compliance.
    Krock K; Pesce A; Ritz D; Thomas R; Cua A; Rogers R; Lipnick P; Kilbourn K
    Pain Physician; 2017 Nov; 20(7):E1107-E1113. PubMed ID: 29149155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six spectroscopic methods for detection of oxidants in urine: implication in differentiation of normal and adulterated urine.
    Paul BD
    J Anal Toxicol; 2004 Oct; 28(7):599-608. PubMed ID: 15516320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance evaluation of three on-site adulterant detection devices for urine specimens.
    Peace MR; Tarnai LD
    J Anal Toxicol; 2002 Oct; 26(7):464-70. PubMed ID: 12423001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference of alum on analysis of methamphetamine in urine specimens.
    Liu CY; Chien CS
    Clin Chem; 1996 Feb; 42(2):338-40. PubMed ID: 8595740
    [No Abstract]   [Full Text] [Related]  

  • 19. Fluorometric determination of the quality of FITC conjugates.
    Körting HJ; Klagge E; Warweg U; Hindersin P
    Virologie; 1977; 28(1):41-3. PubMed ID: 191990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Interpretation of Urine Drug Tests: What Clinicians Need to Know About Urine Drug Screens.
    Moeller KE; Kissack JC; Atayee RS; Lee KC
    Mayo Clin Proc; 2017 May; 92(5):774-796. PubMed ID: 28325505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.